SCHEMBL4763169

SCHEMBL4763169

CC(c1ccccc1)n1c(C=Cc2cnn(Cc3ccccc3C(F)(F)F)c2)c([N+](=O)[O-])c(=O)n(C(C)c2ccccc2)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
ALDH1A1 P00352 4/20 0.34
MAPK1 P28482 2/20 0.34
GNRHR P30968 3/20 0.34
TAS2R8 Q9NYW2 1/20 0.33
NPBWR1 P48145 1/20 0.33
SCD5 Q86SK9 1/20 0.32
MAPT P10636 3/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
DCTPP1 Q9H773 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MITF O75030 1/20 0.31
BLM P54132 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763163 1.00 ADORA2A (0.37) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4764001 0.92 ADORA2A (0.37) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4765675 0.90 ADORA2A (0.36) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4765672 0.90 ADORA2A (0.36) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4765715 0.90 MAPT (0.36) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4765703 0.90 MAPT (0.36) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4766003 0.89 TACR1 (0.33) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4766009 0.89 TACR1 (0.33) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4763383 0.89 ADORA2A (0.38) ADORA2AADORA2BADORA1ALDH1A1MAPK1
SCHEMBL4763386 0.89 ADORA2A (0.38) ADORA2AADORA2BADORA1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed